Beneficial and Therapeutic Potential of Ketone Bodies (KB) in Clinical Practice

Hiroshi Bando^1,2*
1Medical Research/Tokushima University, Tokushima, Japan
²Japan Low Carbohydrate Diet Promotion Association (JLCDPA), Kyoto, Japan

Corresponding Author: Hiroshi BANDO, MD, PhD, FACP ^{ORCID iD}
Address: Tokushima University /Medical Research, Nakashowa 1-61, Tokushima 770-0943, Japan.
Received date: 20 April 2021; Accepted date: 02 June 2021; Published date: 10 June 2021

Citation: Bando H. Beneficial and Therapeutic Potential of Ketone Bodies (KB) in Clinical Practice. Diab Res Open Access. 2021 Jun 10;3(2):30-32.

Copyright © 2021 Bando H. This is an open-access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Keywords: Ketone Bodies, American College of Cardiology, Low Carbohydrate Diet, Cardiovascular, β-Hydroxybutyrate

Abbreviations: KB: Ketone Bodies; ACC: American College of Cardiology; LCD: Low Carbohydrate Diet; CV: Cardiovascular; βHB: β-hydroxybutyrate

Abstract

Various discussion exists concerning ketone bodies (KB) for beneficial effects. In 2021, the American College of Cardiology (ACC) has presented the therapeutic potential of KB for cardiovascular (CV) disease. KB cover 10-15% of cardiac production of ATP, elevation of cardiac energetics, and reduction of cardiac remodeling, inflammation, and oxidative stress.